Lineage specification in glioblastoma is regulated by METTL7B

Cell Rep. 2024 Jun 25;43(6):114309. doi: 10.1016/j.celrep.2024.114309. Epub 2024 Jun 5.

Abstract

Glioblastomas are the most common malignant brain tumors in adults; they are highly aggressive and heterogeneous and show a high degree of plasticity. Here, we show that methyltransferase-like 7B (METTL7B) is an essential regulator of lineage specification in glioblastoma, with an impact on both tumor size and invasiveness. Single-cell transcriptomic analysis of these tumors and of cerebral organoids derived from expanded potential stem cells overexpressing METTL7B reveal a regulatory role for the gene in the neural stem cell-to-astrocyte differentiation trajectory. Mechanistically, METTL7B downregulates the expression of key neuronal differentiation players, including SALL2, via post-translational modifications of histone marks.

Keywords: CP: Cancer; CP: Stem cell research; METTL7B; SALL2; cancer stem cells; cerebral organoids; epigenetics; glioblastoma; in vivo models; lineage specification; neural stem cells; single-cell transcriptomic.

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Astrocytes / pathology
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / pathology
  • Cell Differentiation*
  • Cell Line, Tumor
  • Cell Lineage* / genetics
  • Gene Expression Regulation, Neoplastic
  • Glioblastoma* / genetics
  • Glioblastoma* / metabolism
  • Glioblastoma* / pathology
  • Humans
  • Methyltransferases* / genetics
  • Methyltransferases* / metabolism
  • Mice
  • Neural Stem Cells / metabolism
  • Neural Stem Cells / pathology
  • Organoids / metabolism
  • Organoids / pathology

Substances

  • Methyltransferases